US05502L1052 - AZRX - A2AQDY (LSSI)
AZURRX BIOPHARMA Aktie
Performance
Tag | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
- | - | - | - | -6,86 % | -9,06 % | 224,41 % |
Firmenprofil zu AZURRX BIOPHARMA Aktie
AzurRx BioPharma, Inc. engages in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal disorders. The company is headquartered in Brooklyn, New York and currently employs 12 full-time employees. The firm is engaged in the research and development of non-systemic biologics for the treatment of patients with gastrointestinal (GI) disorders. The firm's product pipeline consists of two therapeutic proteins, such as MS1819 and AZX1101. MS1819 is an acid-resistant secreted lipase produced by Yarrowia lipolytica, known as LIP2, that the Company is developing through recombinant deoxyribonucleic acid (DNA) technology for the treatment of exocrine pancreatic insufficiency (EPI), associated with chronic pancreatitis (CP) and cystic fibrosis (CF). AZX1101 is a recombinant-lactamase combination of bacterial origin under development for the prevention of hospital-acquired infections by resistant bacterial strains induced by parenteral administration of b-lactam antibiotics (known as nosocomial infections), as well as the prevention of antibiotic-associated diarrhea (AAD).
Unternehmensdaten zur AZURRX BIOPHARMA Aktie
Name AZURRX BIOPHARMA
Firma AzurRx BioPharma, Inc.
Symbol AZRX
Website http://www.azurrx.com
Heimatbörse
Lang & Schwarz
WKN A2AQDY
ISIN US05502L1052
Wertpapierart Aktie
Sektor Healthcare
Branche Biotechnology
CEO Mr. James Sapirstein
Land Vereinigte Staaten von Amerika
Währung EUR
Mitarbeiter 0,0 T
Adresse 760 Parkside Ave Ste 304, 11226 Brooklyn
IPO Datum 2016-10-11
Aktien-Splits
Datum | Split |
---|---|
13.09.2021 | 1:10 |
Ticker Symbole
Name | Symbol |
---|---|
NASDAQ | AZRX |
Weitere Aktien
Investoren die AZURRX BIOPHARMA halten haben auch folgende Aktien im Depot:
Die Finanzplattform goSPATZ trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
All rights reserved © LCP GmbH 2024